in Newswire July 26, 2019

Class Action Accuses Pharma Companies of Secretly Reformulating VSL#3 Probiotics Product

Starr et al v. VSL Pharmaceuticals, Inc. et al

Filed: July 23, 2019 § 8:19-cv-02173

Probiotic product VSL#3 is at the center of a proposed class action out of Maryland that claims VSL Pharmaceuticals, Inc. deceived consumers by passing off a cheaper, less effective formulation as the original product.

Last Updated on July 26, 2019 — 4:43 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.